{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:25:34Z","timestamp":1786116334331,"version":"build-2736575974"},"reference-count":25,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Intramural Research Program of the National Institutes of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Oncol.","Current Oncology"],"abstract":"<jats:p>Hereditary kidney cancer syndromes predispose patients to multifocal, bilateral and\/or recurrent renal tumors, requiring repeated interventions over a lifetime. Despite nephron-sparing surgery being the preferred management strategy, some patients ultimately require completion nephrectomy\u2014radical nephrectomy following prior ipsilateral partial nephrectomy\u2014when tumor burden, declining renal function, surgical complications, or pre-transplant indications necessitate definitive kidney removal. Data on outcomes in this population remain limited. We evaluated a prospectively maintained cohort of 58 patients who underwent completion nephrectomy at the National Institutes of Health between 2000 and 2024, following at least one prior ipsilateral partial nephrectomy. Perioperative complication rates and renal functional change were the primary outcomes of interest. Von Hippel\u2013Lindau disease was the most common hereditary diagnosis (62.1%). Open surgery was performed in 56.9% of cases. Overall complications occurred in 43.1% of patients, with 24.1% experiencing a Clavien\u2013Dindo grade \u2265 3 event; perioperative mortality was 6.9%. The median preoperative estimated glomerular filtration rate was 72 mL\/min\/1.73 m2, declining to 50 mL\/min\/1.73 m2 at the first postoperative clinic visit. Completion nephrectomy in hereditary kidney cancer syndrome patients is associated with substantial perioperative morbidity, mortality, and expected renal functional decline. These findings inform patient counseling and surgical decision-making in this high-risk population.<\/jats:p>","DOI":"10.3390\/curroncol33080468","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T08:08:02Z","timestamp":1786003682000},"page":"468","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Completion Nephrectomy Outcomes Following Prior Partial Nephrectomy in Hereditary Kidney Cancer Syndromes"],"prefix":"10.3390","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7231-8980","authenticated-orcid":false,"given":"Patrick D.","family":"Michael","sequence":"first","affiliation":[{"name":"Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Loebach","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Blachman-Braun","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangcheng","family":"Fu","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4253-8568","authenticated-orcid":false,"given":"Braden","family":"Millan","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaskirat","family":"Saini","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6405-9269","authenticated-orcid":false,"given":"Sandeep","family":"Gurram","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Marston","family":"Linehan","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1780-2627","authenticated-orcid":false,"given":"Mark W.","family":"Ball","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Gomella, P.T., Linehan, W.M., and Ball, M.W. (2021). Precision Surgery and Kidney Cancer: Knowledge of Genetic Alterations Influences Surgical Management. Genes, 12.","DOI":"10.3390\/genes12020261"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1159\/000369362","article-title":"Management of von Hippel-Lindau disease: An interdisciplinary review","volume":"37","author":"Schmid","year":"2014","journal-title":"Oncol. Res. Treat."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MOU.0000000000000646","article-title":"Inherited kidney cancer syndromes","volume":"29","author":"Ball","year":"2019","journal-title":"Curr. Opin. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Millan, B., Loebach, L., Blachman-Braun, R., Patel, M.H., Saini, J., Linehan, W.M., and Ball, M.W. (2025). Molecular Genetics of Renal Cell Carcinoma: A Narrative Review Focused on Clinical Relevance. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32060359"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MOU.0000000000000094","article-title":"Nephron-sparing surgery for multifocal and hereditary renal tumors","volume":"24","author":"Metwalli","year":"2014","journal-title":"Curr. Opin. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.juro.2017.09.072","article-title":"Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses","volume":"199","author":"Wood","year":"2018","journal-title":"J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/JU.0000000000004099","article-title":"Cumulative Impact of Serial Partial Nephrectomy for the Treatment of Recurrent Renal Masses","volume":"212","author":"Antony","year":"2024","journal-title":"J. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"454.e9","DOI":"10.1016\/j.urolonc.2024.09.019","article-title":"Multivariate analysis of the parameters affecting the choice of surgical treatment for patients with localized renal cell carcinoma (RCC)","volume":"42","author":"Pikul","year":"2024","journal-title":"Urol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1089\/end.2016.0517","article-title":"Repeat robotic partial nephrectomy: Characteristics, complications, and renal functional outcomes","volume":"30","author":"Watson","year":"2016","journal-title":"J. Endourol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1464-410X.2013.11800.x","article-title":"Repeat robot-assisted partial nephrectomy (RAPN): Feasibility and early outcomes","volume":"111","author":"Autorino","year":"2013","journal-title":"BJU Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1089\/end.2018.0384","article-title":"Laparoscopic completion nephrectomy for local surgical bed recurrence after partial nephrectomy: An analysis of procedural complexity and feasibility","volume":"32","author":"Shah","year":"2018","journal-title":"J. Endourol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"Altman","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/bju.13842","article-title":"Who is at risk of death from nephrectomy? An analysis of thirty-day mortality after 21,380 nephrectomies in 3 years of the British Association of Urological Surgeons (BAUS) National Nephrectomy Audit","volume":"120","author":"Fernando","year":"2017","journal-title":"BJU Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/iju.14461","article-title":"Nomogram predicting 30-day mortality after nephrectomy in the contemporary era: Results from the SEER database","volume":"28","author":"Falagario","year":"2021","journal-title":"Int. J. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.eururo.2008.11.023","article-title":"Thirty-day mortality after nephrectomy: Clinical implications for informed consent","volume":"56","author":"Cloutier","year":"2009","journal-title":"Eur. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/bju.12770","article-title":"Perioperative outcomes of 6042 nephrectomies in 2012: Surgeon-reported results in the UK from the British Association of Urological Surgeons (BAUS) nephrectomy database","volume":"115","author":"Henderson","year":"2015","journal-title":"BJU Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.juro.2011.05.074","article-title":"Complications and failure to rescue after laparoscopic versus open radical nephrectomy","volume":"186","author":"Tan","year":"2011","journal-title":"J. Urol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1681\/ASN.2017020136","article-title":"Incident CKD after radical or partial nephrectomy","volume":"29","author":"Leppert","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"486.e1","DOI":"10.1016\/j.urolonc.2016.05.025","article-title":"The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System","volume":"34","author":"Mason","year":"2016","journal-title":"Urol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"487.e1","DOI":"10.1016\/j.urolonc.2023.09.003","article-title":"Outcomes of and indications for renal transplantation in patients with von Hippel Lindau disease","volume":"41","author":"Antony","year":"2023","journal-title":"Urol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for renal cell carcinoma in von Hippel\u2013Lindau disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(22)01059-5","article-title":"The multispeciality approach to the management of localised kidney cancer","volume":"400","author":"Stewart","year":"2022","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.juro.2011.02.007","article-title":"Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease","volume":"185","author":"Joly","year":"2011","journal-title":"J. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10689-012-9525-7","article-title":"Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma: Clinicopathological long-term follow-up","volume":"11","author":"Jilg","year":"2012","journal-title":"Fam. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1470-2045(25)00099-3","article-title":"Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study","volume":"26","author":"Srinivasan","year":"2025","journal-title":"Lancet Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/8\/468\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:05:36Z","timestamp":1786007136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/8\/468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["curroncol33080468"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33080468","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}